Evaluation of in Vitro Devices on Self-collected Vaginal Swab and Urine Sample for Testing of Human Papilloma Virus (EU-VALHUDES)
European VALidation of HUman Papillomavirus Assays and Collection DEvices for HPV Testing on Self-samples and Urine Samples
Sponsor: Genefirst LTD
This observational or N/A phase trial investigates Carcinoma Cervix Uterine and Carcinoma in Situ and is currently completed. Genefirst LTD leads this study, which shows 9 recorded versions since 2020 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Feb 2023 — Jul 2024 [monthly]
Completed
Status: Recruiting → Completed
-
Dec 2021 — Feb 2023 [monthly]
Recruiting
-
Oct 2021 — Dec 2021 [monthly]
Recruiting
▶ Show 4 earlier versions
-
Jan 2021 — Oct 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Aug 2020 — Nov 2020 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Apr 2020 — Aug 2020 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Genefirst LTD
- Hiantis Srl
- Sciensano
For direct contact, visit the study record on ClinicalTrials.gov .